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Abstract: Aging is a condition which favors the development of atherosclerosis, which has 
been associated with a breakdown in repair processes that occurs in response to cell 
damage. The dysregulation of the biological systems associated with aging are produced 
partly through damage which accumulates over time. One major source of this injury is 
oxidative stress, which can impair biological structures and the mechanisms by which they 
are repaired. These mechanisms are based on the pathogenesis of endothelial dysfunction, 
which in turn is associated with cardiovascular disease, carcinogenesis and aging. The 
dependent dysfunction of aging has been correlated with a reduction in the number and/or 
functional activity of endothelial progenitor cells, which could hinder the repair and 
regeneration of the endothelium. In addition, aging, inflammation and oxidative stress are 
endogenous factors that cause telomere shortening, which is dependent on oxidative cell 
damage. Moreover, telomere length correlates with lifestyle and the consumption of a 
healthy diet. Thus, diseases associated with aging and age may be caused by the long-term 
effects of oxidative damage, which are modified by genetic and environmental factors. 
Considering that diet is a very important source of antioxidants, in this review we will 
analyze the relationship between oxidative stress, aging, and the mechanisms which may 
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be involved in a higher survival rate and a lower incidence of the diseases associated with 
aging in populations which follow a healthy diet. 
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1. Introduction 
Aging is defined as the natural decline in chances of survival which all species suffer with 
advancing age. It is expected that in Europe, by 2025, the size of the elderly population will have 
reached 198 million, 78.5% more than in 1975 [1]. The dysregulation of the biological systems 
associated with aging are produced partly through damage that accumulates over time [2]. 
Understanding the molecular and cellular mechanisms that underlie the aging process would provide a 
good strategy to address the problems presented by the aging of the world’s population.  
Age-specific mortality rates from cardiovascular diseases (CVD) and strokes increase with age 
throughout the later years of life. Thus, the aging process is the main risk factor for the development of 
CVD, and is associated with alterations of the structure and function of vascular components, such as 
the endothelium and vascular smooth muscle cells (VSMCs), through various pathways, including 
oxidative stress, cell senescence and inflammation [3–5].  
Among the biological structures that are progressively affected by aging, the endothelium is one of 
the most important because it is in charge of the regulation of vascular homeostasis by the production 
of nitric oxide (NO) [6]. Previous evidence has demonstrated that in the absence of other risk factors, 
aging per se causes the development of atherosclerosis. Therefore, aging could be considered as an 
independent factor associated with endothelial dysfunction even in the absence of other cardiovascular 
risk factors such as hypertension, diabetes mellitus, hypercholesterolemia, cigarette smoking or a 
sedentary lifestyle, as well as genetic factors [7,8].  
Several studies suggest that the impairment of the endothelial function is a progressive, 
multifactorial phenomenon in the elderly, with several pathophysiological mechanisms contributing to 
the functional deterioration of vascular endothelial cells, and this is considered as one of the main 
processes by which aging increases the risk of CVD and the development of atherosclerosis in  
humans [9–11]. In this sense, there must be a balance between the rate of cellular damage and renewal 
to maintain homeostasis and tissue function. Therefore, the research approaches aimed at preserving or 
improving the endothelial function should play a key role in the prevention of vascular diseases in the 
elderly. One major mechanism involved in the vascular aging process is oxidative stress [8,12]. 
Considerable evidence has been published indicating that increased production of reactive oxygen 
species (ROS) leads to endothelial dysfunction in aging both in animals [13] and in humans [14]. 
However, several other possible mechanisms have been postulated: impairment of the NO  
pathway [8,15,16], activation of inflammatory pathways [17–19], telomere length and telomerase 
activity [20,21], and the senescence of endothelial progenitor cells [22,23] (Figure 1). This complex 
process is controlled by several factors, such as changes in lifestyle, diet and physical activity, as well 
as drug treatments and medication [24–26] (Table 1). In this way, the use and application of these 
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alternatives could prevent and/or treat advanced stages of endothelial dysfunction or act on the 
structural alterations of the vascular wall [27,28].  
Figure 1. Postulated mechanisms involved in the vascular aging process. Vascular aging 
can be induced by different factors as oxidative stress, inflammation, an impairment of NO 
pathway and/or length and activity of telomerase, producing a decrease in cellular turnover 
mechanisms and an accumulation of senescent cells.  
 
Table 1. Effect of dietary nutrients and caloric restriction on cellular damage associated 
with aging. 
Human Study Mechanisms involved Authors’ conclusions 
Landberg et al. Endothelial dysfunction 
Beneficial effects of dietary compounds, fruit, vegetables, fish 
and nuts, on endothelial dysfunction [29] 
Kiecolt-Glaser, J.K.  
et al.  
Telomere length and 
Inflammation 
The lower n-6: n-3 (polyunsaturated fatty acid) PUFA ratios 
may be beneficial for slowing biological  
aging [30,31]  
Weiss, E.P. et al.  Vascular aging 
Studies in animals and humans indicate that caloric restriction 
prevent many of the age-related changes in the structure and 
function of the cardiovascular system [32] 
Scoditti, E. et al. Inflammation 
Mediterranean diet polyphenols suppressed inflammatory 
angiogenesis [33] 
Mirabello, L. et al. Telomere length 
A healthy lifestyle with a diet high in fruit and vegetables 
combined with exercise, lower body mass and not smoking is 
associated with longer telomeres [34] 
Marin, C. et al. 
Endothelial progenitor cell, 
microparticles, oxidative 
stress and telomere length 
The Mediterranean diet is associated with improvement in 
endothelial regeneration capacity, increased number of 
circulating endothelial progenitors cell (EPC), lower levels of 
microparticles, reduce oxidative stress and decreased telomere 
shortening rate [35,36] 
Fernandez, J.M. et al. Endothelial progenitor cell 
The consumption of a Mediterranean diet and exercise led a 
greater decrease in blood pressure and a greater increase in 
EPC number [37] 
Martinez, P. et al. Markers of oxidative stress 
The Mediterranean diet reduces postprandial levels of 
oxidative stress biomarkers such as lipid peroxide, protein 
carbonyl, superoxide dismutase (SOD) activity and plasma 
H2O2 [38] 
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Table 1. Cont. 
Human Study Mechanisms involved Authors’ conclusions 
Cruz-Teno, C. et al. Inflammatory state 
The Mediterranean diet attenuates the postprandial 
inflammatory state, including nuclear transcription  
factor-kappa B (NF-κB), metalloproteinase-9 and tumor 
necrosis factor-α [39] 
Cassidy, A. et al. Telomere length 
The dietary intake of fiber is positively correlated with 
leukocyte telomere length in women and negatively associated 
with dietary intake of polyunsaturated fatty acids, especially 
linoleic acid [40] 
Farzaneh-Far, E. et al. 
Kielcolt-Glaser, J.K.  
et al. 
Telomere shortening 
In patients with coronary artery disease, there was an inverse 
relationship between baseline blood levels of marine omega-3 
fatty acids and the rate of telomere shortening [31,41] 
Yubero-Serrano, E.M.  
et al. 
Oxidative stress  
The Mediterranean diet, rich in virgin olive oil, induced a 
reduction in the degree of oxidative stress. In addition, 
coenzyme Q10 supplementation can improve antioxidant 
activity of cell membranes in the elderly [24,25] 
Animal model study Mechanisms involved Author’s conclusion 
Jung, K.J. et al. Inflammation 
Caloric restriction appears to attenuate vascular NF-κB 
induction and endothelial activation in aged rats[42,43] 
McCarty, M.F. Nitric oxide production  
A low-fat, whole-food, vegan diet or exercise training would 
be expected to decrease the risk of common age-related 
diseases [26] 
In vitro study Mechanisms involved Author’s conclusion 
Csiszar, A. et al. Mitochondria 
Resveratrol induces mitochondrial biogenesis in cultured 
endothelial cells and in endothelia of mice with accelerated 
vascular aging [22,27] 
Csiszar, A. et al. and 
Ungvari, Z. et al. 
Inflammation and oxidative 
stress 
In vitro studies suggest that the molecular mechanisms of 
resveratrol-mediated vasoprotection involve an inhibition of 
NF-κB and an upregulation of endothelial nitric oxide synthase 
(eNOS) and antioxidant enzymes [28,44–46] 
Tang, Y. et al. 
Cellular senescence and 
oxidative stress 
In vitro studies suggest that resveratrol protects vascular cell 
senescence reducing the production of reactive oxygen species 
(ROS) [23,28]  
Greater knowledge of the molecular and cellular mechanisms involved in vascular dysfunction 
associated with aging would provide a better understanding with which we could develop suitable 
strategies, use specific targets to mitigate the effect of vascular aging, prevent cardiovascular diseases 
and improve the quality of life of the elderly. After that, we will analyze the mechanisms involved in 
vascular dysfunction related with aging and review the possible benefits of dietetic strategies with 
potential to promote cardiovascular health in the elderly.  
For this review, we have carried out a systematic search of the Pubmed database from 1990 to 
February 2013. The keywords used in the Pubmed search were “aging, oxidative stress, vascular aging, 
diet and Mediterranean diet.” Our search strategy yielded 13,078 citations. Irrelevant papers were 
excluded by title and abstract reviews, which narrowed it down to 126 manuscripts. We reviewed 
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scientific articles considering the scientific evidence that included: (1) The effect of oxidative stress on 
vascular aging; (2) the effect of nutrients and dietary intervention on vascular aging; (3) repairing the 
damage induced by oxidative stress and the inflammatory process in aging. 
2. Vascular Aging and Oxidative Stress  
The underlying mechanisms in vascular aging are complex, and involve different pathways [47]. 
Oxidative stress is caused by an imbalance between the production of reactive oxygen and a biological 
system’s ability to readily detoxify the reactive intermediates or easily repair the resulting damage. A 
large body of evidence indicates that oxidative stress is increased during aging, which is caused by the 
imbalance between ROS production and antioxidant defense capability (enzymatic and non-enzymatic 
antioxidants) [12]. Various hypotheses suggest that the decline in endothelial function during aging is 
due to an increase in superoxide anion (O2
−) levels, which lead to a decrease in the availability  
of NO [48]. 
The main sources of ROS in the endothelium are composed of a variety of cell types, including 
VSMCs, endothelial cells and mononuclear cells. ROS include superoxide anion (O2
−), hydrogen 
peroxide (H2O2), hydroxyl radical (OH), hypochlorous acid (HOCl), NO and peroxynitrite (ONOO
−). 
The antioxidant enzyme superoxide dismutase (SOD) rapidly dismutates O2
− to H2O2, and subsequently, 
the H2O2 is eliminated by glutathione peroxidase (GSH-Px) and catalase and turned into water. 
Aging activates the enzymes involved in ROS production, such as nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase, xantine oxidase, uncoupled NO synthase and 
cyclooxygenase and it inactivates the antioxidant system, including SOD, (GSH-Px) and catalase, 
leading to an increase in ROS production and a decrease in ROS degradation. However, the results 
obtained from different studies in which antioxidant defense levels were determined were 
contradictory. While some authors observed an age-related decrease in superoxide dismutase (SOD) 
and glutathione peroxidase (GSH-Px) activities and a decline in plasma antioxidant capacity [46], 
others found an increase in the activity of SOD and GSH-Px [49].  
Another source for aging-induced vascular dysfunction is oxidative stress generated by 
mitochondria [44]. Under physiological conditions, mitochondria produce O2
− and H2O2, so that 
mitochondrial DNA (mtDNA) is particularly exposed to oxidative damage. During aging, the result is 
a reduction in the number of mitochondria and a higher expression of dysfunctional proteins, which 
leads to the malfunction of the respiratory chain energy, increasing O2
− production and a depletion in 
energy supply to cells [50]. 
The implication of oxidative stress in the development of vascular aging has been described in both 
laboratory animals [51,52] and humans [14,53]. Upregulation of pro-oxidants and downregulation of 
antioxidants leads to consequences in vascular remodeling by VSMCs proliferation, migration and 
extracellular matrix remodeling [54], generating an impairment of endothelial function, inflammation, 
apoptosis and senescence of endothelial cells [55].  
3. Vascular Aging and Inflammation 
Abundant experimental and clinical data show that aging is also associated with chronic low-grade 
inflammation. Because there is an important cross talk among inflammatory processes, generation of 
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ROS and endothelial dysfunction [56], recent studies showed that ROS per se can act as  
molecule-signaling activating pathways which regulate inflammatory processes, including secretion of 
inflammatory mediators. Inflammation itself promotes cellular oxidative stress [53]. ROS interacts 
with different redox-sensitive transcriptional factors such as activator protein 1 (AP-1) and nuclear 
transcription factor-kappa B (NF-κB), increasing the gene expression of cytokines (TNFα, IL-1β and  
IL-6) and adhesion molecules (Intercellular Adhesion Molecule 1 (ICAM-1) and vascular cell 
adhesion protein 1 (VCAM-1)). An increase in inflammatory cytokine levels contributes to a  
pro-inflammatory status, facilitates the development of vascular dysfunction, and promotes endothelial 
apoptosis in aging [57]. In this regard, it is significant that caloric restriction can attenuate the altered 
signaling transduction of inflammatory processes, which are mediated through NF-κB and AP-1, and 
endothelial activation in aged rats [42,43,58]. Furthermore, it has numerous beneficial effects on the 
aging cardiovascular system by a reduction in the inflammatory process in the vasculature and heart, 
and it could protect against the development of arterial stiffness with increasing aging [32].  
4. Vascular Aging and Alteration of the NO Pathway 
Nitrosative stress is defined as the ratio of nitrosants and antioxidants similar to oxidative stress, but 
with the additional involvement of reactive nitrogen species. Oxidative/nitrosative stress represent the 
imbalance in the production and the elimination of reactive oxygen and nitrogen species. Many 
functions of the vascular endothelium are modulated by NO, which is able to confer vasoprotective 
and cardioprotective effects, including the production of smooth muscle relaxation [10]; inhibition of 
platelet activation and adhesion to the surface of the endothelium [59]; disruption of synthesis and 
expression of cytokines and cell adhesion molecules [47]; preservation of endothelial progenitor cell 
(EPC) function; and regulation of tissue energy metabolism. NO is synthesized from L-arginine by the 
enzyme NO synthase (NOS). There are three known NOS isoenzymes: the constitutive endothelial 
(eNOS) and neuronal (nNOS) isoforms, which produce the NO involved in regulatory pathways, and 
the inducible (iNOS) NOS isoform, which produces an uncontrolled NO synthesis, related with 
inflammatory responses. As we mentioned previously, the reduction of NO availability caused by 
excess ROS production is a major cause of endothelial dysfunction in aging, altering vascular  
homeostasis [60,61]. This reduced NO production may be controlled by several mechanisms: (1) a 
deficiency in NOS substrates and cofactors; (2) the presence of endogenous eNOS inhibitors; and (3) a 
lower expression and/or activity of eNOS. 
4.1. Deficiency in NOS Substrates and Cofactors 
One of the mechanisms responsible for a low NO availability during aging is the presence of a 
lower concentration of L-arginine, which is used as eNOS substrate to produce NO in endothelial cells. 
The oxidation of L-arginine produces NO and L-citruline by endothelial nitric oxide synthase (eNOS) 
(Figure 2) [62]. The contribution of an increased expression and/or activity of arginase, the enzyme 
that degrades L-arginine, to age-related endothelial dysfunction could explain a decrease in substrate 
availability for eNOS and the consequent reduction of NO synthesis [63]. This is not the only 
mechanism that leads to impaired NO production, but it also contributes to an enhanced production of 
ROS by NOS (Figure 2). Although the role of arginase in endothelial dysfunction in elderly patients 
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requires further investigation, some studies suggest that this alteration described in animals might also 
appear in humans [64]. 
Figure 2. Mechanisms responsible for a low NO availability during aging. The oxidation 
of L-arginine produces NO and L-citruline by the endothelial nitric oxide synthase (eNOS). 
The presence of low levels of L-arginine contribute to a low NO availability during aging. 
 
Tetrahydrobiopterin (BH4), a cofactor essential for NOS activity, is an allosteric factor in the 
coupling of the oxidase and reductase domains of eNOS [65]. The regulation of eNOS by the oxidation 
of the cofactor BH4 is an important contributor to endothelial dysfunction. ROS induces eNOS 
uncoupling, altering its catalytic activity. eNOS uncoupling produces ROS rather than NO, and 
therefore, when BH4 is limited or under oxidative stress conditions, this cofactor produces superoxide, 
leading to peroxinitrite [65,66]. Several studies have shown that the administration of BH4 to older 
adults causes a selective improvement in endothelial vasorelaxation, demonstrating that BH4 
potentially leads to eNOS recoupling in aged human vasculature [67].  
4.2. Presence of Endogenous eNOS Inhibitors 
An endogenous L-arginine analog, asymmetric dimethylarginine (ADMA), blocks the synthesis of 
NO by the inhibition of the NOS active site. ADMA is a naturally occurring amino acid found in 
plasma and various tissues. An enhanced production of ADMA has been associated with impaired 
endothelial function in humans [68]. A possible role for this compound has been proposed in the 
physiological process of aging, as a positive correlation has been reported in healthy subjects between 
the plasmatic levels of ADMA and age [69]. Moreover, the effect ADMA has on accelerating 
endothelial cells senescence has been previously described [70]. 
4.3. Lower Expression and/or Activity of eNOS 
Several studies have evaluated the expression of the enzyme eNOS in arteries of aged animals, but 
the results obtained have not provided definitive conclusions. While some studies, performed in 
smooth muscle cells, showed increased eNOS protein levels in the aorta and mesenteric arteries [71], 
others have reported no significant changes in eNOS expression in the same cellular type [72]. In 
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human endothelial cells from peripheral veins and the brachial artery, there were no changes in eNOS 
expression during the aging process [73]. The discrepancies found among the published results could 
be due to the use of different animal models, arterial types (in human or animals) and the difference in 
age between old and young groups; however, there is a greater consensus over the reduced activity of 
the eNOS enzyme in aging [74]. Also, eNOS is regulated at post-transcriptional level involving PI3 
kinase/Akt-dependent phosphorylation at Ser117, resulting in an increase in NO production from 
endothelial cells. In aged animals, the PI3K/Akt pathway is diminished and eNOS gene expression and 
enzymatic activity levels decrease [75]. However, the involvement in this low rate of eNOS 
phosphorylation in human vascular aging needs to be confirmed. 
5. Vascular Aging and Cellular Senescence  
Considerable evidence indicates that an imbalance between the magnitude of vascular injury and 
the capacity for repair appears to play an important role in age-related impaired endothelial function. 
These impairments are attributed to a decrease in the number and function of endothelial progenitor 
cells (EPCs) and/or impaired cell replication.  
5.1. Number and Function of Endothelial Progenitor Cells (EPCs) 
Accumulating evidence suggests that circulating bone marrow-derived EPCs contribute to vascular 
repair and regeneration, accelerating re-endothelialization and protecting against the initiation and 
progression of atherosclerosis [76]. EPCs express markers of both hematopoietic stem cells and 
endothelial cells on their surface and represent a very small subset of mononuclear cells, between 
0.002% and 0.01% in peripheral blood and 0.2%–1% in umbilical cord blood [77]. Circulating EPC 
levels reflect vascular repair capacity, so that a reduction in the number of circulating EPCs predicts 
the occurrence of cardiovascular events [76]. In this situation, EPCs are mobilized from the bone 
marrow into circulation, reaching vascular injury areas where they are able to contribute to new blood 
vessel formation. Several studies have demonstrated that circulating EPCs are subject to changes 
associated with aging, which negatively affect their number and/or function. Consistent with this 
notion, the number of EPCs in healthy individuals is reduced with age [78]. Also, EPC mobilization is 
significantly impaired in older individuals compared with younger subjects [79] and the function of 
EPCs from older individuals also appears to be disrupted, according to in vitro studies [80]. Moreover, 
flow-mediated vasodilation was significantly correlated with the number of circulating EPCs in 
patients who had varying degrees of cardiovascular risk (but no history of cardiovascular disease) [81]. 
There is a wide range of environmental factors which influence EPC generation and function. 
Previous studies demonstrated that human EPCs express high levels of antioxidant enzymes as 
compared to mature endothelial cells [82]. Aging produces an impairment of their antioxidant 
capacity, reducing levels and activity of antioxidant enzymes such as glutathione peroxidase-1 [82].  
Aging is also known to be associated with the development of chronic low grade inflammation, 
which contributes to impaired EPC function [56]. Deregulation of the pro-inflammatory cytokine 
TNF-α has been associated with the pathogenesis of atherosclerosis. Indeed, vascular aging is 
associated with upregulation of TNF-α, which can induce premature senescence in highly proliferative 
EPCs [83]. A decrease in EPC mobilization and function may be related to the reduced capacity of the 
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aging endothelium to generate NO and the increased production of ROS [84]. The accumulation of 
oxidized low-density lipoprotein (oxLDL) with age also contributes to a reduction in the number of 
circulating EPCs, due to its inhibitory effect on eNOS expression and activity [85]. Another factor 
involved in EPC regeneration during aging is endothelial senescence, a process through which the EPC 
vascular repair mechanisms are damaged. The therapeutic use of the introduction of telomerase into 
EPCs has been shown to extend lifespan and improve vasculogenesis of these cells [86].  
5.2. Impaired Cell Replication and Telomere Shortening in Aged Arteries 
Telomeres are repeats of DNA–protein complexes, located at the ends of chromosomes, and are 
essential to the stability of chromosome and cell replication. The formation, maintenance and repair of 
telomeres are performed by the enzyme telomerase, but as a consequence of semiconservative DNA 
replication, the extreme terminals of chromosomes are not duplicated completely, causing successive 
shortening of the telomeres with each round of cell division [87]. Telomere length is regulated by  
pro-inflammatory cytokines and oxidative stress [88,89]: the latter promotes telomere shortening 
during cell replication in vitro and stimulates the synthesis of pro-inflammatory cytokines [20]. There is 
evidence of a correlation between ROS levels and the rate of telomere shortening. These studies suggest 
that an increase in intracellular ROS level could lead to an acceleration in the rate of telomere shortening. 
The progressive shortening of telomeres leads to senescence, apoptotic cell death, or the oncogenic 
transformation of somatic cells in various tissues. Telomere length, which can be affected by various 
lifestyle factors, may determine overall health, lifespan, and the rate at which an individual ages [90]. 
As a normal cellular process, telomere length decreases with age [91]. Recent studies in rodents 
have shown a causal effect of telomerase deficiency and telomere shortening on healthy aging and 
premature mortality [92,93]. Similarly, the length of telomeres isolated from endothelial cells of 
human arteries shows a strong inverse correlation with age [88]. The endothelial cell senescence 
observed during the normal aging process seems to be accelerated in the diseases associated with aging 
and in particular CVD [94].  
5.3. Microparticles 
Microparticles (MPs) are small fragments or vesicles from different types of cells (endothelial cells, 
platelets and leukocites) which are released during cell apoptosis, inflammatory activation and cellular 
stress [95]. They are made up of material from their cells of origin, which is a general characteristic of 
MPs [96]. MPs are present in plasma from healthy subjects, but their concentrations change in several 
clinical conditions. MP concentrations increase in patients with cardiovascular risk factors and after 
cardiovascular events [97]. Moreover, certain pharmacological treatments, used to treat cardiovascular 
diseases, reduce plasma MP concentrations. However, the pathophysiological effects of MPs in vivo 
are still poorly understood. Studies performed with MPs (in vitro or isolated ex vivo) have shown that 
they can influence some of the processes involved in atherogenesis, such as endothelial function, 
angiogenesis, inflammation and thrombosis, which suggests that MPs are not only markers, but they 
are also involved in cardiovascular diseases [98]. 
Several studies have reported an increase in MPs in aged diabetic rats [99] and an increase in 
leukocyte-derived MPs in aged mice with thrombosis [100]. In humans, there is an increase in  
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platelet-derived MPs in the elderly compared to healthy individuals [101]. All these findings show the 
role of MPs in vascular pathology and suggest that, by themselves, they are the key to promoting 
premature vascular aging cellular senescence. 
Recent studies have indicated that MPs have an effect on the endothelium through the increase in 
oxidative stress and endothelial inflammation, reducing the production of NO, or stimulating the 
platelet and macrophage adhesion to endothelial cells [102–104]. Burger et al. [104] have observed 
that MPs stimulate the production of ROS through NADPH oxidase [105], mitochondria, and NOS 
ciclooxigenase [106], inducing premature senescence of the endothelial cells. These results suggest 
that MPs contribute to the progression of vascular aging mechanism through a “feed-forward” method, 
where the increased formation of MPs from senescent endothelial cells also promotes cellular 
senescence through an increase in ROS production. 
6. Mediterranean Diet: Does It Prevent Endothelial Aging? 
The Mediterranean diet is a healthy diet which includes fish, vegetables, fruit, whole grains, 
legumes, olive oil, and less red meat and dairy products. Changes in lifestyle habits, such as diet and 
moderate exercise, can influence vascular repair mechanisms. Different studies have shown that a 
healthy diet and exercise induce a reduction in cell damage and endothelial dysfunction, both of which 
are factors responsible for reducing cardiovascular risk in the elderly [24,107].  
Several intervention studies have suggested that the consumption of flavonoid-rich foods such as 
tea, red wine [108], cocoa and soya can improve endothelial function in patients with manifest 
cardiovascular and cerebrovascular disease [109,110]. In this way, Perez-Martinez et al., showed that 
the consumption of a Mediterranean diet reduced postprandial levels of oxidative stress biomarkers 
such as lipid peroxide, protein carbonyl, SOD activity and plasma H2O2 compared to a saturated  
fat-rich diet in metabolic syndrome subjects [38]. Similarly, this diet significantly attenuated  
the postprandial inflammatory state, including NF-κB, metalloproteinase-9 and tumor necrosis  
factor-α [33,39]. In addition, consumption of a Mediterranean diet and exercise led to a greater 
decrease in blood pressure and a greater increase in the number of EPC compared with the same diet 
without exercise [37]. 
Antioxidant supplementation can play an important role in delaying or reducing many of the 
adverse effects of aging. In this regard, it is interesting to review the beneficial effects that can be 
obtained through nutrition in the prevention of the deleterious effects induced by oxidative stress. The 
repair or prevention effects have been attributed to the presence of antioxidants, mainly contained in 
plant foods such as fruit, vegetables, whole grains, nuts and seeds [29,111,112]. Several studies 
indicate that vitamin E supplementation can improve antioxidant activity of cell membranes in elderly 
subjects [113,114]. Also, antioxidants such as the polyphenolic compound have anti-aging properties. 
In addition, a recent randomized controlled trial has shown that omega-3-polyunsaturated fatty acid 
supplementation lowered the concentration of serum pro-inflammatory cytokines [30]. On the other 
hand, Csiszar et al. indicated the possibility that supplementation of resveratrol, a diet-derived 
polyphenol, may confer significant vasoprotection in elderly humans [45,115,116]. 
Similarly, studies performed with elderly people have demonstrated that the consumption of a 
Mediterranean diet produced an increase in NO bioavailability, with a consequent improvement in 
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endothelium-dependent endothelial function [25]. It is also associated with an improvement in 
endothelial regeneration capacity, producing an increased number of circulating EPCs and lower levels 
of microparticles, compared with the consumption of a saturated fatty acid-rich diet and a low-fat and 
high-carbohydrate diet, enriched with α-linolelic acid [35,37].  
An improvement in lifestyle habits is also positively correlated with telomere length. In fact, 
telomere length has been associated with nutritional status in both human and animal models (Table 1). 
A healthy lifestyle, with a diet high in fruit and vegetables combined with exercise, lower body mass 
and not smoking is associated with longer telomeres [34]. Another study suggests that lower n-6:n-3 
PUFA ratios can influence cell aging, increasing telomere length with a reduction of the n-6:n-3 ratio 
in a diet supplemented with omega-3 (n-3) PUFA [31]. A protein-restricted diet produced an increase 
in lifespan and a reduction in growth rate in rats, but also, the increased lifespan in such animals was 
associated with significantly longer telomeres in the kidney [117]. Cassidy et al. [40] demonstrated 
that leukocyte telomere length in women was positively correlated with dietary intake of fiber and 
negatively associated with dietary intake of polyunsaturated fatty acids, especially linoleic acid. Recent 
studies have shown that, in patients with coronary artery disease, there was an inverse relationship 
between baseline blood levels of marine omega-e fatty acids and the rate of telomere shortening [41]. 
Similarly, there is evidence to show the effect of the quality and quantity of dietary fat on telomere 
length, depending on the degree of oxidative stress that these diets produce. Therefore, the 
consumption of a saturated fatty acid-rich diet or a carbohydrate-rich diet induces telomere attrition, as 
a result of cell replication, which can be accelerated by the presence of increased oxidative  
stress [36]. However, the consumption of a Mediterranean type diet (monounsaturated fat-rich diet), 
rich in virgin olive oil, improves this profile and leads to a reduction in the degree of oxidative  
stress [24,25] and a decrease in the rate of telomere shortening [35]. Antioxidants can potentially 
protect telomeric DNA from oxidative damage caused by extrinsic and intrinsic DNA damaging 
agents, so a diet lacking antioxidants led to shorter telomeres, whereas consumption of an antioxidant 
rich diet such as vitamin C, E and β-carotene was associated with longer telomeres [35,118]. 
7. Conclusions and Future Expectations 
Healthy dietary habits and moderate physical exercise improve endothelial dysfunction and 
oxidative stress, which are two factors involved in cardiovascular alterations associated with vascular 
aging. The consumption of a Mediterranean diet improves endothelial regenerative capacity as a result 
of a balance between cellular damage and repair. The mechanisms involved in this process can be 
associated with a decreased release of free radicals and a reduction in oxidative stress, due to the 
protective effects of both the monounsaturated fat and antioxidants present in this diet. Moreover, a 
Mediterranean diet may protect against endothelial cell senescence, generating a decrease in 
intracellular oxidative stress, telomere shortening and cellular apoptosis. All these mechanisms may be 
involved in an increased lifespan and a lower incidence of the diseases associated with aging present in 
populations which consume a Mediterranean-type diet.  
These findings show that cellular oxidative stress, one of the major sources of damage in the 
dysregulation of biological systems, is closely linked to the generation of ROS and this can contribute 
to the development of cellular senescence, which leads to accelerated aging of the organism [119]. 
Int. J. Mol. Sci. 2013, 14 8880 
 
Senescent endothelial cells play a more important role morphologically and functionally in the 
development of atherosclerosis than normal cells. Epidemiological data indicate that young subjects 
with early signs of vascular senescence have an increased risk of developing CVD, so this suggests 
that the prevention or delay of the aging process could be used as a prophylaxis of vascular aging.  
Antioxidant supplementation can play an important role in delaying or reducing many of the 
adverse effects of aging. Its repair or prevention effects have been attributed to the presence of 
antioxidants, mainly contained in plant foods such as fruit, vegetables, whole grains, nuts and seeds. 
Several studies have indicated that vitamin E and/or coenzyme Q10 supplementation can improve 
antioxidant activity of cell membranes in the elderly [24,25,120]. 
Dietary fat may also modulate oxidative stress in human endothelial cells, and a Mediterranean diet 
may bring considerable health benefits. Esposito et al. [121] have shown that in overweight or obese 
men, a prolonged adherence to a Mediterranean-style diet with or without caloric restriction, is 
associated with amelioration of multiple risk factors including a better cardiovascular risk profile and a 
reduced level of oxidative stress, all of which are markers of aging. Several researchers have suggested 
that the Mediterranean diet has a protective effect against cardiovascular, metabolic, cancer and other 
age-related diseases and degenerative diseases [24,25,122,123]. The Mediterranean dietary pattern is 
characterized by a high intake of fruit and vegetables, olive oil as the main source of fat intake, a low 
consumption of meat products, and moderate wine consumption. Visioli et al. [124] have linked the 
benefits of the Mediterranean diet with the protective role of phenolic compounds present in this type 
of diet, leading to a reduction of oxidative stress. Recent studies performed in the elderly have 
demonstrated that the Mediterranean diet protected endothelial cells against oxidative stress and 
prevented the development of cell senescence [35]. This study has shown that the consumption of a 
Mediterranean diet induces lower intracellular oxidative stress by decreasing levels of ROS. Therefore, 
this diet could modulate intracellular oxidative stress in the elderly, possibly due to minor components 
with antioxidant properties included in the Mediterranean diet. Recent studies confirm that excessive 
oxidative stress on endothelial cells promotes apoptosis [125]. Thus, the Mediterranean diet and/or the 
micronutrients present in this diet may participate in the regulation of these pathways, leading to lower 
apoptosis in endothelial cells [35]. 
In summary, dietary intervention, and particularly a Mediterranean-style diet, improves vascular 
dysfunction and microcirculation, and can play a role in the protection against the chronic diseases 
related to aging. 
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